Imagine losing your visual connection to the world
Imagine your independence slipping away

Age-related macular degeneration is the leading cause of blindness in older adults
Imagine having difficulty reading bedtime stories to your children

Diabetic retinopathy is the leading cause of blindness in working-age adults
At Kodiak we are helping to improve millions of lives

Kodiak is designing and developing novel therapies for the treatment of retinal diseases

Latest News

Kodiak Sciences Announces Upcoming Presentation of KSI-301 12-Week Phase 1a Study Data at Angiogenesis, Exudation, and Degeneration 2019 Meeting
Kodiak Sciences Added to Russell 2000®, 3000® and Microcap® Indexes
Kodiak Sciences Announces Completion of 12-Week Phase 1a Study of KSI-301 in Patients with Diabetic Macular Edema Demonstrating Safety and Durability of Responses Following Single Dose of Intravitreal Anti-VEGF Antibody Biopolymer Conjugate

Pushing the Boundaries

At Kodiak, we are developing disruptive products and platforms to prevent and treat the leading causes of blindness

ABC Platform^TM

CLiP Platform^TM

Our Pipeline

We are committed to progressing and expanding our pipeline towards the prevention, treatment and, when possible, the cure of high-prevalence ophthalmology diseases